Navigation Links
Global Pharm Holdings Group Announces First Quarter 2011 Financial Results
Date:5/16/2011

g activities:Short-term loan borrowing-219,713Short-term loan repayments(1,367,704)-Bank acceptance237,663(219,713)Dividend paid to the former shareholders-(3,208,521)Net cash used in financing activities(1,130,041)(3,208,521)Net increase (decrease) in cash and cash equivalents4,586,501(3,026,663)Effect of exchange rate changes on cash and cash equivalents47,769(3,245)Cash and cash equivalents - beginning of period4,271,4987,455,147Cash and cash equivalents - end of period$8,905,768$4,425,239-Supplemental disclosure of cash flow information:Cash paid for interest$10,747$829Cash paid for income taxes$1,179,482$690,986For Additional Information ContactGlobal Pharm Holdings Group, Inc.Ms. Susan LiuPhone: +86-755-3693-9373 (Shenzhen, China)Email: susanliu@globalpharmholdings.comCCG Investor Relations, Inc.Ms. Linda Salo, Account ManagerPhone: +1-646-922-0894 (New York, USA)Email:linda.salo@ccgir.com
'/>"/>
SOURCE Global Pharm Holdings Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 Aileron Therapeutics, Inc. - ... Global Markets Direct,s, ,Aileron Therapeutics, Inc. - Product ... the Aileron Therapeutics, Inc.,s pharmaceutical research and development ... the current therapeutic developmental pipeline of Aileron Therapeutics, ... therapeutics assessment by drug target, mechanism of action ...
(Date:9/30/2014)... ATLANTA , Sept. 30, 2014  Alimera Sciences, ... company that specializes in the research, development and commercialization ... received a $25 million advance from Hercules Technology Growth ... payment is the second and final advance under the ... United Kingdom , Alimera Sciences Limited, ...
(Date:9/30/2014)... , N.J. and NEW BRUNSWICK, N.J., Sept. 30, 2014 ... agreement that allows Kessler Foundation and New Jersey ... biomedical research, education and patient care programs has ... and chief executive officer of Kessler Foundation and ... Jersey Health Foundation. "The experience of ...
Breaking Medicine Technology:Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2
... JERUSALEM, October 20 Oramed Pharmaceuticals,Inc. (OTCBB: ORMP.OB; ... today that its poster entitled "A novel GLP-1,analog delivered ... been accepted for presentation at the Diabetes Technology,Society,s Ninth ... , "The selection of Oramed ...
... Oct. 20 Aethlon Medical, Inc. (OTC Bulletin Board: ... Aethlon Hemopurifier® is effective in capturing the current pandemic ... is the first-in-class medical device able to selectively remove ... During invitro studies, the Hemopurifier® removed 68% ...
Cached Medicine Technology:Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Society's Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA) 2Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus 2Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus 3
(Date:9/30/2014)... Legislation passed in 2003 to slow the spiraling ... to treat Medicare patients has had no meaningful impact ... researchers in the Journal of Clinical Oncology ... outpatient chemotherapy to treat colorectal and lung cancers, and ... prescribe those drugs following the implementation of the recent ...
(Date:9/30/2014)... 30, 2014 Research by UC Irvine immunologists reveals ... light on a vital process that determines how the ... online version of Nature Immunology , neurology professor ... Institute for Immunology colleagues describe a critical mechanism underlying ... the bloodstream. , A T cell is a type ...
(Date:9/30/2014)... 30, 2014 Fat Burning Kitchen , ... best-selling author Mike Geary that is helping people learn the ... into a fat-burning machine in less than 24 hours has ... , “In our culture that is becoming so obsessed ... decipher what is really fact and fiction when it comes ...
(Date:9/30/2014)... White Plains, NY (PRWEB) September 30, 2014 ... (HPCW) recently hosted its annual “In Celebration” gala, ... furthering the nonprofit’s mission of striving to provide ... individuals and families facing a serious or life-limiting ... Westchester Country Club in Rye, NY and recognized ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Two revolutionary procedures ... treatment of gum disease a far less painful ... past. , “If you’ve ever felt electric shock waves surge ... sip a cold beverage, it’s possible you already know the ... who is a general dentist in West Palm Beach, and ...
Breaking Medicine News(10 mins):Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:UCI study uncovers important process for immune system development 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3
... PHILADELPHIA, May 15 The Mobile Massage Team ( ... services for corporate wellness programs, promotional events, and special affairs, ... the 7th Annual Yoga Unites(R) for Living Beyond Breast Cancer ... May 17, from 8:00 a.m. to 12:00 p.m. on the ...
... Paul Capital Healthcare today announced that New York-based partner, ... forms of financing at the 2009 BIO International Convention. ... non-dilutive financing options that can meet the needs of ... and Other Non-traditional Forms of Financing," is scheduled for ...
... PTN ) announced today results for its third quarter ... million, or $0.00 per basic and diluted share, for the quarter ... million, or $0.06 per basic and diluted share, for the same ... 31, 2009 were $5.2 million, compared to $0.7 million for the ...
... Researchers at Intermountain Medical Center in Salt Lake City ... atrial fibrillation, a fairly common heart rhythm disorder, and ... , In a study presented Friday, May 15, at ... Heart Rhythm Society in Boston, researchers unveiled findings from ...
... (NYSE Amex:, SVA ), a leading developer and provider of vaccines ... March 31, 2009. , , Recent Highlights, ... sole provider of, approximately $12.8 million ... inactivated hepatitis A vaccine, Healive, to China,s Ministry of Public, ...
... - U.S. and international thought leaders featured -SAN FRANCISCO, ... trusted resource for clinical trial management systems, this week ... institutions and industry partners at its annual meeting in ... to discuss a variety of initiatives and to hear ...
Cached Medicine News:Health News:Paul Capital Healthcare to Participate in Panel on Non-Traditional Forms of Financing 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 2Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 3Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 4Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 5Health News:Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to be held on May 15, 2009 6Health News:Study makes first connection between heart disorder and Alzheimer's disease 2Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 2Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 3Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 4Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 5Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 6Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 7Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 8Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 9Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 10Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 11Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 12Health News:Sinovac Reports Unaudited First Quarter 2009 Financial Results 13Health News:Top Academic Medical Centers, Research Institutions, Partners Gather, Share Experiences, Success Stories at Velos Annual Meeting 2Health News:Top Academic Medical Centers, Research Institutions, Partners Gather, Share Experiences, Success Stories at Velos Annual Meeting 3
...
...
Bimod, acetabular cup "Xl" UHMWHDPE....
Metal on metal hip acetabular cups available for both cemented and cementless applications, the Biomet Merck metal on metal articulation hip system (M2aTM) combines proven materials with the latest i...
Medicine Products: